Hhlr Advisors, Ltd.

13F Holdings History for BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC)

Symbol: ONC on Nasdaq
Investment type: Equity / Ordinary shares, par value $0.0001 per share
Latest Disclosed Ownership: 68.6M shares
Security Ownership: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

HHLR Advisors, Ltd. ownership in BeOne Medicines Ltd. Ordinary shares, par value $0.0001 per share (ONC)

2025-05-13 - HHLR Advisors, Ltd. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 68.6M shares of BeOne Medicines Ltd. Ordinary shares, par value $0.0001 per share (ONC). This represents 4.9% percent ownership of the company. In their previous filing dated 2025-03-03, HHLR ADVISORS, LTD. had reported owning 92.8M shares, indicating a decrease of -26.1% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
HHLR Advisors, Ltd.	4.9%	-25.7%	$16.4B	68.6M	-24,254,600	-26.1%	$238.51	13D/A	5/9/2025	13 May 2025 16:15:10
HHLR Advisors, Ltd.	6.7%		$22.1B	92.8M			$238.51	13D/A	3/3/2025	3 Mar 2025 21:30:19

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	8.06%		$250M	1.03M			$242.07	Q2 2025
3/31/2025	7.95%	-21.3%	$282M	1.03M	-2,770,100		$272.17	Q1 2025
12/31/2024	24.3%	-8.78%	$703M	3.8M	-1,372,500	-26.5%	$184.71	Q4 2024
9/30/2024	25.5%		$1.16B	5.18M			$224.51	Q3 2024
6/30/2024	18.2%		$739M	5.18M			$142.67	Q2 2024
3/31/2024	17.6%		$810M	5.18M			$156.39	Q1 2024
12/31/2023	18.8%		$934M	5.18M			$180.36	Q4 2023
9/30/2023	20.8%		$931M	5.18M			$179.87	Q3 2023
6/30/2023	19.7%	-1.12%	$923M	5.18M	-295,353	-5.4%	$178.30	Q2 2023
3/31/2023	20.9%		$1.18B	5.47M			$215.53	Q1 2023
12/31/2022	25.4%		$1.2B	5.47M			$219.94	Q4 2022
9/30/2022	19.4%		$738M	5.47M			$134.82	Q3 2022
6/30/2022	19%		$886M	5.47M			$161.85	Q2 2022
3/31/2022	21.5%		$1.03B	5.47M			$188.60	Q1 2022
12/31/2021	22.9%		$1.48B	5.47M			$270.93	Q4 2021
9/30/2021	26%		$1.99B	5.47M			$363.00	Q3 2021
6/30/2021	19.3%		$1.88B	5.47M			$343.19	Q2 2021
3/31/2021	18.8%		$1.9B	5.47M			$348.08	Q1 2021
12/31/2020	11.2%		$1.41B	5.47M			$258.39	Q4 2020
9/30/2020	11.9%		$1.57B	5.47M			$286.44	Q3 2020
6/30/2020	9.42%		$1.03B	5.47M			$188.40	Q2 2020
3/31/2020	9.08%		$674M	5.47M			$123.11	Q1 2020
12/31/2019	11.3%		$907M	5.47M			$165.76	Q4 2019
9/30/2019	9.21%	+1.74%	$670M	5.47M	+1,034,306	+23.3%	$122.46	Q3 2019
6/30/2019	12.3%		$550M	4.44M			$123.95	Q2 2019
3/31/2019	16.3%		$586M	4.44M			$132.00	Q1 2019
12/31/2018	25.8%		$622M	4.44M			$140.26	Q4 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.